Notes Payable (Details Narrative) - USD ($)											1 Months Ended	12 Months Ended
	Sep. 14, 2015	Aug. 13, 2015	Mar. 14, 2015	Feb. 18, 2015	Feb. 02, 2015	Dec. 31, 2014	Dec. 31, 2014	Dec. 09, 2014	Nov. 05, 2014	Jun. 25, 2013	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Sep. 15, 2015	Jun. 16, 2015	Mar. 03, 2015	Dec. 31, 2013
Debt instruments maturity date												Sep. 15, 2015
Percentage of convertible notes payable						10.00%	10.00%					10.00%	10.00%
Note automatically convert into common stock equivalent price												$ 0.035
Warrants exercise price per share												$ 0.035
Amortization of capitalized financing costs												$ 114,128	$ 15,648
Amortization of debt discount												675,025	46,150
Stockholder's percentage										20.00%
Interest expense												$ 902,698	$ 117,306
Dr. Lippa [Member]
Accrued interest payable															$ 877
Stockholder's percentage															10.00%
Working capital requirements															$ 40,000
Advances total																	$ 75,000
Dr. Arnold S. Lippa [Member]
Repaid the working capital advances including accrued interest											$ 102
Dr. Arnold S. Lippa [Member] | Maximum [Member]
Due to officer																$ 150,000
Percentage of interest rate for due on demand working capital																0.22%
10% Convertible Notes Payable [Member]
Proceeds from issuance of private placements						$ 85,000
Converted into common stock												18,311,079	10,674,107
Number of conversion into common shares attributable to accrued interest												1,753,936	116,964
Accrued interest payable						$ 4,093	$ 4,093					$ 61,388	$ 4,093
Warrants [Member]
Debt instruments maturity date		Sep. 15, 2016
Warrants exercise price per share						$ 0.031	$ 0.031						$ 0.031
Fair value of beneficial conversion feature value		$ 206,689										290,394
Fair value of warrants												$ 289,106
Number of extension warrants issued during period		8,903,684
Exercise of warrant during period	1,017,000
Cashless basis issuance of common stock during period	47,109
Warrants exercised cashless basis gross	$ 35,595
Convertible notes prinicpal amount		$ 579,500
Accrued interest payable		$ 43,758
Percentage of unpaid interest multiplied		50.00%
Divided		$ 0.035
Warrants extension, description		the New Warrants and extension of the original Warrants, of approximately 55% for the Notes, including accrued interest, and approximately 45% for the New Warrants and extension of the original Warrants.
New Warrants Issuance [Member] | Investors [Member]
Debt instruments maturity date												Sep. 15, 2016
Fair value of beneficial conversion feature value												$ 206,689
Extension of original warrants amount												$ 277,918
Number of original warrants issued during period												16,577,142
Charged interest expense												$ 81,249
Interest expense												60,425
Aurora Capital LLC [Member]
Warrants exercise price per share									$ 0.035
Financing cost paid in cash									$ 33,425
Common shares issuable upon conversion									955,000
Warrants issued for placement									16,557,142
Samyang Optics Co Inc [Member]
Notes payable						$ 399,774	$ 399,774					$ 399,774	$ 399,774
Samyang Optics Co Inc [Member] | US Dollars [Member]
Secured note payable value										$ 400,000
Samyang Two-Year Detachable [Member]
Warrants exercise price per share												$ 0.056
Number of placement warrants												4,000,000
Financing costs												$ 21,370
Percentage of proceeds of borrowing attributed to debt instrument												64.00%
Call right consideration per share												$ 0.001
Weighted average closing price per share												$ 0.084
Warrants expiration date												Jun. 25, 2014
Accrued note payable compounded annual interest percentage												12.00%
Warrant Purchase Agreement [Member] | Investors [Member]
Debt instruments maturity date									Sep. 15, 2015
Private Placement [Member]
Warrants exercise price per share														$ 0.035
Financing consisting costs related note payable paid in cash					$ 93,110
Percentage of common stock share convertible notes					42000000.00%
Black-scholes option-pricing model					$ 12,726
Financing costs					129,776
Value of placement warrants					36,666
Amortization of capitalized financing costs												$ 114,128	15,648
Amortization of debt discount												267,821	21,285
Amortization of debt discount related value attributed beneficial conversion feature												$ 265,529	$ 24,865
Private Placement [Member] | Initial Closing [Member]
Debt instruments maturity date									Sep. 15, 2015
Financing consisting costs related note payable paid in cash									$ 16,695
Percentage of common stock share convertible notes									7.00%
Number of placement warrants									477,000
Common stock exercisable price per share									$ 0.07
Private Placement [Member] | Second Closing Fees [Member]
Financing consisting costs related note payable paid in cash									$ 700
Number of placement warrants									20,000
Private Placement [Member] | Third Closing Fees [Member]
Financing consisting costs related note payable paid in cash									$ 3,500
Private Placement [Member] | Fourth Closing Fees [Member]
Financing consisting costs related note payable paid in cash									14,700
Private Placement [Member] | 2014 Closing 1 [Member]
Black-scholes option-pricing model									19,986
Private Placement [Member] | 2014 Closing 2 [Member]
Black-scholes option-pricing model									614
Private Placement [Member] | 2014 Closing 3 [Member]
Black-scholes option-pricing model									$ 3,340
Private Placement [Member] | Third Closing Fees [Member]
Number of placement warrants									100,000
Private Placement [Member] | Fourth Closing Fees [Member]
Number of placement warrants									420,000
Private Placement [Member] | 2014 Closing [Member]
Number of placement warrants									597,000
Premium Financing Agreement [Member]
Accrued note payable compounded annual interest percentage			5.08%
Premium Financing Agreement [Member] | Ten Monthly Installments [Member]
Debt periodic payment			$ 3,697
10% Convertible Notes Payable [Member]
Proceeds from issuance of private placements									$ 238,500
Proceeds from issuance of private placements					$ 210,000		$ 85,000	$ 46,000
Terminated short-term convertible notes and warrants				$ 579,500
Number of extension warrants issued during period				16,577,142
Promissory Note [Member]
Early repayment of promissory note, date										Feb. 14, 2016